Come up with a name for your new list and we'll add to it:
Heptares Therapeutics raised a round of funding on February 25, 2008. Investors include
MVM Life Science Partners.
Heptares Therapeutics focuses on the discovery and development of novel drugs acting at G-protein coupled receptors (GPCRs). Heptares StaR (Stabilized Receptor) technology enables thermo-stabilization…